Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis
Related Experiment Video
Updated: Dec 26, 2025

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
Published on: March 18, 2010
Marcel Hohl1, Aditya Mojumdar2, Sarem Hailemariam3
1Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Abstract:
The DNA damage response (DDR) comprises multiple functions that collectively preserve genomic integrity and suppress tumorigenesis. The Mre11 complex and ATM govern a major axis of the DDR and several lines of evidence implicate that axis in tumor suppression. Components of the Mre11 complex are mutated in approximately five percent of human cancers. Inherited mutations of complex members cause severe chromosome instability syndromes, such as Nijmegen Breakage Syndrome, which is associated with strong predisposition to malignancy. And in mice, Mre11 complex mutations are markedly more susceptible to oncogene- induced carcinogenesis. The complex is integral to all modes of DNA double strand break (DSB) repair and is required for the activation of ATM to effect DNA damage signaling. To understand which functions of the Mre11 complex are important for tumor suppression, we undertook mining of cancer genomic data from the clinical sequencing program at Memorial Sloan Kettering Cancer Center, which includes the Mre11 complex among the 468 genes assessed. Twenty five mutations in MRE11 and RAD50 were modeled in S. cerevisiae and in vitro. The mutations were chosen based on recurrence and conservation between human and yeast. We found that a significant fraction of tumor-borne RAD50 and MRE11 mutations exhibited separation of function phenotypes wherein Tel1/ATM activation was severely impaired while DNA repair functions were mildly or not affected. At the molecular level, the gene products of RAD50 mutations exhibited defects in ATP binding and hydrolysis. The data reflect the importance of Rad50 ATPase activity for Tel1/ATM activation and suggest that inactivation of ATM signaling confers an advantage to burgeoning tumor cells.
Insights
Mutations in the Mre11 complex impair DNA damage signaling, specifically ATM activation, while preserving DNA repair. This separation of function suggests a mechanism by which cancer cells may evade tumor suppression.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- The DNA damage response (DDR) is crucial for maintaining genomic integrity and preventing cancer.
- The Mre11 complex and ATM kinase are key components of the DDR, implicated in tumor suppression.
- Mutations in Mre11 complex genes are found in human cancers and cause instability syndromes.
Purpose of the Study:
- To investigate which functions of the Mre11 complex are essential for its tumor-suppressive role.
- To analyze cancer genomic data for mutations in MRE11 and RAD50.
- To functionally characterize these mutations in yeast and in vitro.
Main Methods:
- Mining of cancer genomic data from Memorial Sloan Kettering Cancer Center.
- Modeling of 25 recurrent and conserved MRE11 and RAD50 mutations in Saccharomyces cerevisiae.
- In vitro biochemical assays to assess DNA repair and ATM/Tel1 activation.
Main Results:
- A significant fraction of tumor-derived MRE11 and RAD50 mutations caused a separation of function.
- These mutations impaired Tel1/ATM activation while largely retaining DNA repair capabilities.
- RAD50 mutations affected ATP binding and hydrolysis, crucial for Tel1/ATM activation.
Conclusions:
- Rad50 ATPase activity is critical for ATM signaling activation.
- Inactivation of ATM signaling by specific Mre11 complex mutations may provide a survival advantage to developing tumor cells.
- Understanding these specific functional defects can inform cancer therapy strategies.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
DNA Damage can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

